Report ID: 10078324 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Biologics Safety Testing Industry was valued at USD 2.80 Billion in the year 2017. Global Biologics Safety Testing Industry is further estimated to grow at a CAGR of 12.4% from 2019 to reach USD 7.06 Billion by the year 2025. North America region holds the highest Industry share in 2017 and Asia Pacific Industry is considered as the fastest growing Industry in the forecasted period. At a country level, the U.S and Canada are projected to grow strongly in the coming years.
Major market players in Biologics Safety Testing Industry are Sigma Aldrich Corp, Lonza group, SGS, Merck, Intertek, Charles River Laboratories International Inc., WuXi PharmaTech, BSL Bioservice, Cytovance Biologics Inc., Toxikon Corp., and brief information of 11 companies will be provided in the report. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.
Biologics Safety Testing Industry:
Strength:
Increasing research and investments in the healthcare industry
Weakness:
Time consuming approval process
Opportunities:
Technological advancements
Pharmaceutical emerging Industry
Threats:
Availability of skilled labors
The Global Biologics Safety Testing is segmented as by products & Services, by Test Type, by application, and by region. On the basis of products & services, the Industry is segmented as Kits & Reagents, Services, and Instruments of which Kits & Reagents holds the highest Industry share.
Biologics Safety Testing Industry Segmentation:
By Test Type
• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication and Characterization Tests
• Bioburden Tests
• Residual Host Contaminant Detection Tests
• Adventitious Agent Detection Tests
• Other tests
By Applications
• Vaccine & Therapeutics Development
• Blood and Blood-Related Products Testing
• Cellular and Gene Therapy
• Tissue and Tissue-Related Products Testing
• Stem Cell Research
By Products and Services
• Kits & Reagents
• Services
• Instruments
By Region
• North America
o USA
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Rest of Europe
• APAC
o China
o India
o Japan
o Rest of Asia-Pacific
• RoW
o Latin America
o Middle East & Africa
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10078324 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
